Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$140,963,022
+$61,909,711 QoQ
Shares Held
117,525
+36.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#322
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Williams Jones Wealth Management, LLC. holds $303,933,088 across 10 Drug Manufacturers - General names. LLY ranks #1 (46.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
117,525 | $140,963,022 | |
| 2 | JNJ |
Johnson & Johnson
|
373,829 | $94,941,351 | |
| 3 | AMGN |
Amgen Inc
|
110,298 | $39,941,111 | |
| 4 | ABBV |
AbbVie Inc.
|
50,099 | $12,606,912 | |
| 5 | MRK |
Merck & Co., Inc.
|
57,783 | $7,425,115 | |
| 6 | PFE |
Pfizer Inc
|
162,713 | $3,918,129 | |
| 7 | NVS |
Novartis AG
|
11,157 | $1,748,525 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
11,845 | $1,496,497 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,963,022 | 117,525 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $79,053,311 | 85,949 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $90,913,637 | 84,596 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $57,421,091 | 75,257 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $69,902,014 | 89,672 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $76,405,760 | 92,511 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $22,150,996 | 28,693 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,993,027 | 27,082 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,586,975 | 23,843 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $17,620,794 | 22,650 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $12,702,409 | 21,791 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,266,838 | 20,976 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,600,958 | 20,472 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,486,516 | 18,888 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,602,680 | 18,048 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,289,035 | 16,357 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,377,030 | 16,584 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,917,541 | 13,680 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,926,743 | 14,216 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,268,664 | 14,147 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,163,033 | 18,138 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,498,764 | 18,728 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,207,960 | 19,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,545,944 | 17,200 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,751,492 | 16,759 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,205,648 | 15,900 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||